Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Mid-Day Market Update: Nasdaq Drops 100 Points; NeuroSense Therapeutics Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 100 points on Monday.

The Dow traded down 0.78% to 34,482.95 while the NASDAQ fell 0.73% to 13,792.22. The S&P also fell, dropping, 0.32% to 4,449.03.

Also check this: ExInsiders Buy Over $7M Of 3 Penny Stocks


Leading and Lagging Sectors


Energy shares jumped by 3.4% on Monday. Meanwhile, top gainers in the sector included BP Prudhoe Bay Royalty Trust (NYSE:BPT), up 13% and Camber Energy, Inc. (NYSE:CEI) up 12%.


In trading on Monday, consumer discretionary shares fell by 0.9%.


Top Headline


The Chicago Fed National Activity Index declined to 0.51 in February from 0.59 in the previous month.


Equities Trading UP


Hudson Capital Inc. (NASDAQ:HUSN) shares shot up 40% to $2.8894 after the company reported its Fr8PrivateFleet has already secured new and existing Fr8App customers, including one of Mexico's largest food producers.


Shares of BitNile Holdings, Inc. (NASDAQ:NILE) got a boost, shooting 45% to $0.8120 after the company said its EV charging subsidiary TurnOnGreen will be acquired by BitNile subsidiary Imperalis.


NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) shares were also up, gaining 372% to $7.36 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.


Equities Trading DOWN

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares tumbled 69% to $2.2792 after releasing topline results from its Phase 1 SEAL study evaluating ADAIR, an abuse-deterrent formulation of immediate-release (IR) dextroamphetamine for attention deficit hyperactivity disorder (ADHD). The study did not meet its primary endpoint, Emax Drug Liking. ADAIR scored similarly to what was observed in an earlier proof-of-concept study.


Shares of Imperial Petroleum Inc. (NASDAQ:IMPP) were down 36% to $1.52 after the company announced a secondary offering.


Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) was down, falling 42% to $0.28 after the company said it would terminate its URIROX-2 Study to reduce kidney stone disease progression.

Also check out: Bristol-Myers Squibb And 2 Other Stocks Sold By Insiders


Commodities

In commodity news, oil traded up 6.1% to $111.11, while gold traded up 0.2% to $1,933.20.


Silver traded up 1.4% Monday to $25.425 while copper fell 0.6% to $4.7105.



Euro zone

European shares were mixed today. The eurozone’s STOXX 600 gained 0.12%, London’s FTSE 100 gained 0.63%, while Spain’s IBEX 35 Index fell 0.19%. The German DAX dropped 0.41%, French CAC 40 fell 0.48% and Italy’s FTSE MIB Index rose 0.52%.

Annual producer inflation in Germany surged a fresh record high for of 25.9% in February from 25% in January.


Economics


The Chicago Fed National Activity Index declined to 0.51 in February from 0.59 in the previous month.


Check out this: Executives Buy More Than $1B Of 4 Stocks


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 81,410,100 cases with around 997,930 deaths. India confirmed a total of at least 43,009,390 cases and 516,510 deaths, while Brazil reported over 29,630,480 COVID-19 cases with 657,260 deaths. In total, there were at least 471,192,130 cases of COVID-19 worldwide with more than 6,101,910 deaths.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.